Appendix 4C

+Rule 4.7B

Quarterly report for entities subject to Listing Rule 4.7B

Introduced 31/03/00 Amended 30/09/01, 24/10/05, 17/12/10, 01/09/16

Name of entity ResApp Health Limited ABN Quarter ended ("current quarter") 30 June 2017 51 094 468 318

Consolidated statement of cash flows

Current quarter

$A'000

Year to date (12 months)

$A'000

  1. Cash flows from operating activities

    1. Receipts from customers

    2. Payments for

      1. research and development

      2. product manufacturing and operating costs

      3. advertising and marketing

      4. leased assets

      5. staff costs

      6. administration and corporate costs

      7. Dividends received (see note 3)

      8. Interest received

      9. Interest and other costs of finance paid

      10. Income taxes paid

      11. Government grants and tax incentives

      12. Other (provide details if material)

      13. 1.9 Net cash from / (used in) operating activities

      -

      -

      (1,224)

      (3,273)

      -

      -

      (20)

      (40)

      -

      -

      (319)

      (1,090)

      (301)

      (1,243)

      -

      -

      44

      205

      (1)

      (5)

      -

      -

      -

      -

      -

      -

      (1,821)

      (5,446)

      1. Cash flows from investing activities
        1. Payments to acquire:

          1. property, plant and equipment - -

          2. businesses (see item 10) - -

          3. investments - -

          4. Consolidated statement of cash flows

            Current quarter

            $A'000

            Year to date (12 months)

            $A'000

            (d) intellectual property

            -

            -

            (e) other non-current assets

            -

            -

            2.2

            Proceeds from disposal of:

            (a) property, plant and equipment

            -

            -

            (b) businesses (see item 10)

            -

            -

            (c) investments

            -

            -

            (d) intellectual property

            -

            -

            (e) other non-current assets

            -

            -

            2.3

            Cash flows from loans to other entities

            -

            -

            2.4

            Dividends received (see note 3)

            -

            -

            2.5

            Other (provide details if material)

            -

            -

            2.6

            Net cash from / (used in) investing

            -

            -

            activities

            1. Cash flows from financing activities

              1. Proceeds from issues of shares

              2. Proceeds from issue of convertible notes

              3. Proceeds from exercise of share options

              4. Transaction costs related to issues of shares, convertible notes or options

              5. Proceeds from borrowings

              6. Repayment of borrowings

              7. Transaction costs related to loans and borrowings

              8. Dividends paid

              9. Other (provide details if material)

              10. 3.10 Net cash from / (used in) financing activities

              -

              -

              -

              -

              -

              -

              -

              -

              -

              -

              - 266

              -

              -

              -

              -

              -

              -

              -

              266

              1. Net increase / (decrease) in cash and cash equivalents for the period
                1. Cash and cash equivalents at beginning of quarter/year to date

                2. Net cash from / (used in) operating activities (item 1.9 above)

                3. Net cash from / (used in) investing activities (item 2.6 above)

                4. Net cash from / (used in) financing activities (item 3.10 above)

                5. 10,376 13,735

                  (1,821) (5,446)

                  - -

                  - 266

                  Consolidated statement of cash flows

                  Current quarter

                  $A'000

                  Year to date (12 months)

                  $A'000

                  4.5 Effect of movement in exchange rates on cash held

                  4.6 Cash and cash equivalents at end of quarter

                  -

                  -

                  8,555

                  8,555

                  5. Reconciliation of cash and cash equivalents

                  at the end of the quarter (as shown in the consolidated statement of cash flows) to the related items in the accounts

                  Current quarter

                  $A'000

                  Previous quarter

                  $A'000

                  5.1

                  Bank balances

                  8,555

                  10,376

                  5.2

                  Call deposits

                  -

                  -

                  5.3

                  Bank overdrafts

                  -

                  -

                  5.4

                  Other (provide details)

                  -

                  -

                  5.5

                  Cash and cash equivalents at end of

                  8,555

                  10,376

                  quarter (should equal item 4.6 above)

                  Current quarter

                  $A'000

                  170

                  1. Payments to directors of the entity and their associates
                    1. Aggregate amount of payments to these parties included in item 1.2

                    2. Aggregate amount of cash flow from loans to these parties included in item 2.3

                    3. Include below any explanation necessary to understand the transactions included in items 6.1 and 6.2

                      1. Director fees, salary and super;

                      2. Consultancy fees; and

                      3. Reimbursements.

                      4. Current quarter

                        $A'000

                      5. Payments to related entities of the entity and their associates
                        1. Aggregate amount of payments to these parties included in item 1.2

                        2. Aggregate amount of cash flow from loans to these parties included in item 2.3

                        3. Include below any explanation necessary to understand the transactions included in items 7.1 and 7.2

                          Total facility amount at quarter end

                          $A'000

                          Amount drawn at quarter end

                          $A'000

                          -

                          -

                          -

                          -

                          -

                          -

                        4. Financing facilities available Add notes as necessary for an understanding of the position
                          1. Loan facilities

                          2. Credit standby arrangements

                          3. Other (please specify)

                          4. Include below a description of each facility above, including the lender, interest rate and whether it is secured or unsecured. If any additional facilities have been entered into or are proposed to be entered into after quarter end, include details of those facilities as well.

                          5. 9. Estimated cash outflows for next quarter

                            $A'000

                            9.1

                            Research and development

                            (1,666)

                            9.2

                            Product manufacturing and operating costs

                            -

                            9.3

                            Advertising and marketing

                            -

                            9.4

                            Leased assets

                            -

                            9.5

                            Staff costs

                            (369)

                            9.6

                            Administration and corporate costs

                            (252)

                            9.7

                            Other (provide details if material)

                            -

                            9.8

                            Total estimated cash outflows

                            (2,287)

                            10. Acquisitions and disposals of business entities

                            (items 2.1(b) and 2.2(b) above)

                            Acquisitions

                            Disposals

                            10.1

                            Name of entity

                            -

                            -

                            10.2

                            Place of incorporation or registration

                            -

                            -

                            10.3

                            Consideration for acquisition or disposal

                            -

                            -

                            10.4

                            Total net assets

                            -

                            -

                            10.5

                            Nature of business

                            -

                            -

                      ResApp Health Limited published this content on 20 July 2017 and is solely responsible for the information contained herein.
                      Distributed by Public, unedited and unaltered, on 19 July 2017 23:03:15 UTC.

                      Original documenthttps://www.resapphealth.com.au/wp-content/uploads/2017/07/1692835.pdf

                      Public permalinkhttp://www.publicnow.com/view/EF1AC7D3C3783B8D62FF36AAA9A6ACD8621FE720